Medical device company Neovasc has added two co-inventors to three of its patents, settling a dispute with a competitor, Edwards Lifesciences.
The US Federal Trade Commission has issued a final approval of Fresenius Medical Care’s $2 billion acquisition of medical device company NxStage Medical.
Massachusetts-based Medrobotics has failed to convince the EU General Court that its trademark for ‘See More. Reach More. Treat More.’ should be registered.
Stanford University has accused genetic testing company Natera of infringing two patents that cover a non-invasive method of testing if transplanted organs are being rejected.
The EU General Court yesterday, March 20, annulled a European Union Intellectual Property Office (EUIPO) decision and handed a trademark victory to Spain-based Prim.
The Trump administration has named Ned Sharpless, director of the National Cancer Institute, as the Food and Drug Administration's (FDA) acting commissioner.
Switzerland-based Novartis today, March 12, failed to convince the EU General Court that its ‘Smartsurface’ trademark should be registered for contact lenses.
The US International Trade Commission has instituted an investigation into certain blood separation and cell preparation devices.
The US International Trade Commission has begun an investigation into whether a Danish company’s dental and orthodontic scanners and software infringed an American company’s patents.
The US Court of Appeals for the Federal Circuit yesterday rejected the University of Florida’s argument that its sovereign immunity protected a patent from section 101 scrutiny.